GuideReduce Send-out Testing Costs
The BioPlex 2200 System offers an extensive test menu, which allows laboratories to expand in-house testing. This reduces reference laboratory expenses, and further minimizes the operational costs associated with managing send-out testing. The BioPlex 2200 System is a high-throughput analyzer that ensures much faster turnaround times than send-out testing, which can improve patient outcomes.
The BioPlex 2200 System offers diverse capabilities, including:
-
- On-board test capacity: up to 55 different autoimmune, infectious disease, and specialty immunoassay tests
-
- Result throughput: Up to 1,400 results per hour (1,200 in the U.S.)
Reduce Costs with Lean Thinking
Embracing Lean laboratory practices can minimize costs by eliminating operational waste and optimizing the efficiency of staff resources. The BioPlex 2200 System is a fully automated, random-access, multiplexing analyzer that is specifically designed to maximize the principles of Lean operations. Its capabilities allow laboratories to streamline testing processes, which contributes to cost reductions and improved productivity.
Reduce Costs with BioPlex 2200 Automation
The BioPlex 2200 System is a fully automated multiplexing analyzer that significantly enhances operational efficiencies. Automation technologies allow the BioPlex 2200 System to minimize operator interactions and simplify testing processes, which directly translates to cost savings for clinical laboratories.
-
Reduce Technologist Hands-on Time
The BioPlex 2200 System automates manual testing processes, reduces patient sample handling, and eliminates reagent preparation. This minimizes technician hands-on time, improves result throughput, and reduces the risk of human errors that lead to costly retesting. Additionally, the BioPlex 2200 System can be integrated with total laboratory automation (TLA) track lines to further reduce processes that consume technologist time.
Improve Workflow Efficiency
The BioPlex 2200 System automates testing processes and analyzer maintenance tasks. This allows technologists to focus their efforts on complex activities that require their expertise, which enhances laboratory efficiencies and boosts productivity.
Reduce Testing Errors
By automating manual processes, the BioPlex 2200 System reduces the risk of human errors that lead to testing failures. Additionally, the BioPlex 2200 System utilizes integrated QC technology that can detect testing problems immediately, and long before traditional QC procedures identify a failure. Retesting is costly and causes workflow bottlenecks that delay results.
-
Simplify Staff Allocation
Thanks to its automation capabilities and intuitive operation, the BioPlex 2200 System makes it easy for technologists to attain proficiency. This allows laboratories to cultivate a versatile workforce, which improves operational efficiency and versatility.
Reduce Labor Costs
The BioPlex 2200 System uses automation and multiplex technology to reduce technologist workloads. Fewer technologists are required to process more tests, which translates into cost savings for the laboratory.
Reduce Training Requirements
The BioPlex 2200 System utilizes automation to simplify the process of achieving and maintaining operational proficiency. Easy-to-use analyzers expedite the training of existing and new staff, helping expand staff competency.
Improve Result Throughput
The BioPlex 2200 System uses multiplex technology to deliver exceptional result throughput and fast turnaround times. This capability is essential for patient care, enabling healthcare providers to make timely and informed decisions for their patients.
Reduce Costs with Analyzer Consolidation
The BioPlex 2200 System offers an extensive test menu for autoimmune, infectious disease, and specialty testing, which allows laboratories to consolidate multiple analyzers onto one fully automated multiplexing system. Reducing the number of different test methods improves operational efficiencies and testing workflows and can reduce costs.
-
Reduce Technologist Hands-on Time
Consolidating test methods onto a single platform simplifies workflow and reduces hands-on time. This minimizes the complexity of managing multiple instruments and allows technologists to focus on tasks that best utilize their expertise.
Streamline Workflow Efficiency
Consolidating testing from multiple analyzers onto a BioPlex 2200 System improves efficiency by eliminating process redundancies, reducing operator hands-on time, and optimizing operational workflow.
Reduce Waste
Consolidating multiple test methods onto an efficient BioPlex 2200 System reduces reagent and consumable supply waste. By generating less waste, clinical laboratories are aligned with environmentally conscious practices and can benefit from substantial cost savings.
-
Reduce Training Requirements
Compared to utilizing multiple test methods, a single BioPlex 2200 System streamlines operations and simplifies training demands. This allows laboratories to expand staff proficiency.
Minimize Space and Storage Requirements
Laboratory space is a limited resource. Consolidating testing from multiple analyzers onto a BioPlex 2200 System can free up valuable space and reduce storage demands. This creates more organized and efficient workspaces and opens opportunities to expand laboratory testing capabilities.
Reduce Costs with Test Method Efficiencies
The BioPlex 2200 System uses multiplex technology to generate more results with fewer tests. This effectively minimizes technologist hands-on time and improves testing efficiency, which can result in substantial cost savings for clinical laboratories.
-
More Test Results with Less Effort
Multiplex technology allows the BioPlex 2200 System to generate multiple results with a single test. This reduces the number of individual tests, calibrations, and QC runs that technologists perform, which translates to substantial cost savings.
Minimize Testing Errors
Quality control beads are incorporated into BioPlex 2200 reagents to monitor the integrity of every test. Multiplex technology detects testing errors immediately and before traditional QC to minimize the risk of costly retesting.1
-
Reduce Consumption
Multiplex technology allows more test results to be generated from fewer reagents and consumable supplies, and significantly less patient sample volume.
Remote Support
BRiCare remote support reduces downtime by allowing Bio-Rad technical support teams to perform analyzer troubleshooting remotely. This reduces technologist hands-on time and provides field service engineers with analyzer data, enabling them to make repairs more quickly and to minimize costly downtime.
Reduce Costs by Eliminating Unnecessary Testing
Clinical laboratory stewardship practices aim to optimize patient care while controlling healthcare costs. This is achieved by implementing strategies to enhance the efficiency of laboratory testing by utilizing appropriate tests and reducing excessive testing.2 The BioPlex 2200 System uses advanced automation and multiplex technology to improve efficiency, eliminate unnecessary testing, and reduce laboratory costs. For example, the BioPlex 2200 ANA Screen panel can produce up to 14 results with a single test (up to 12 results in the U.S.).
BioPlex 2200 ANA Screen Panel
1 Test = 14 Individual Results
† RNP A and RNP 68 are a composite result in the U.S.
‡ Composite result
14 Separate Tests
-
Reduce Calibration and QC Testing Processes
Because multiplex technology allows multiple tests to be combined into a single reagent, BioPlex 2200 test panels only require a single calibration and control run for each panel, compared to conventional test methods that require a separate calibration and control run for each individual assay. This significantly reduces reagent wastage, testing processes, and costs when compared to using separate individual test methods.
Streamline Test Panels
By utilizing multiplex test panels, the BioPlex 2200 System generates multiple individual results with a single test. This reduces the number of tests being performed and improves result throughput, compared to processing multiple individual tests separately.
-
Streamline Testing Algorithms
With traditional methods, testing algorithms require technologists to manage and process sequential individual tests. The BioPlex 2200 System eliminates reflex testing by allowing technologists to add additional results without the need to perform subsequent testing. This significantly reduces workload, enhances workflow efficiency, and improves result throughput.
IgA Verification
The BioPlex 2200 Celiac IgA Panel uses multiplex technology to verify IgA levels without the need for additional testing. This approach helps to reduce costs, streamline workflow, and improve result turnaround time by eliminating unnecessary IgA testing.
The BioPlex 2200 System Can Increase Clinical Laboratory Revenue
Clinical laboratories are faced with a multitude of challenges for maintaining financial viability that extend beyond driving down costs. One of the biggest obstacles they face is the intense competition for laboratory testing services. Staying ahead of the competition requires that laboratories continuously explore innovative solutions to expand their diagnostic service capabilities.3 This includes maximizing the quality of their results and minimizing turnaround times.
Another challenge is due to the ever-present focus on reducing healthcare costs. The uncertainties surrounding testing reimbursement rates and constantly evolving healthcare policies can significantly affect laboratory testing revenue. This puts pressure on clinical laboratories to find a balance between offering cost-effective services and maintaining financial sustainability.
The BioPlex 2200 System allows clinical laboratories to efficiently expand their testing capabilities, which can provide opportunities to improve revenue.
Expand Testing Outreach
The BioPlex 2200 System has a comprehensive test menu, which makes it easy for clinical laboratories to expand and diversify their testing revenue. A broad specialty testing menu is an effective way to distinguish laboratories as leaders and innovators by providing more comprehensive solutions. Additionally, multiplex technology greatly improves result throughput and turnaround time, which is essential for clinicians to provide the highest level of patient care. Improving testing capabilities provides an opportunity for clinical laboratories to expand outreach and attract new healthcare providers.
Increase Testing Revenue
The BioPlex 2200 System offers an extensive menu of autoimmune, infectious disease, and specialty assays that allows clinical laboratories to expand testing and significantly increase testing revenue.
Navigating Cost and Revenue: The BioPlex 2200 Solution
The BioPlex 2200 System offers a comprehensive solution to manage diagnostic testing costs and clinical laboratory revenue growth. As the healthcare landscape evolves, laboratories must proactively address the challenges of reduced reimbursements and intense competition. The BioPlex 2200 System offers a comprehensive solution to manage diagnostic testing costs and clinical laboratory revenue growth. As the healthcare landscape evolves, laboratories must proactively address the challenges of reduced reimbursements and intense competition.
By providing a comprehensive test menu and multiplex technology, the BioPlex 2200 System allows clinical laboratories to expand in-house testing and minimize operational costs. Advanced automation streamlines processes, reduces errors, and optimizes staff efficiency. The BioPlex 2200 System provides clinical laboratories with a tool that will allow them to adopt Lean principles, consolidate methods, and eliminate unnecessary testing to reduce costs and enhance operational effectiveness.
As laboratories strive to improve their testing services and attract new healthcare providers, the BioPlex 2200 System provides a versatile solution to expand and diversify revenue streams and secure a sustainable financial future.
References
- Reithel J (2021). Minimizing laboratory errors with automation. https://cdn.mlo-online.com/files/base/ebm/mlo/document/2021/07/MLO202108_CEStory_Test.60f8586c3b0df.pdf, accessed August 25, 2023.
- White T et al. (2021). Strategies for laboratory professionals to drive laboratory stewardship. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339222/, accessed August 25, 2023.
- Scott K (2020). Exposing Clinical Labs Budget Blind Spots. https://www.aacc.org/cln/articles/2020/march/exposing-clinical-labs-budget-blind-spots, accessed August 25, 2023.
